MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Profit Before Tax | ₹1,671 Cr | ₹1,975 Cr | ₹1,692 Cr | ₹1,438 Cr | ₹865 Cr |
Adjustment | ₹298 Cr | ₹31 Cr | ₹-5.66 Cr | ₹105 Cr | ₹87 Cr |
Changes In working Capital | ₹167 Cr | ₹-586 Cr | ₹-95 Cr | ₹-140 Cr | ₹-9.74 Cr |
Cash Flow after changes in Working Capital | ₹2,136 Cr | ₹1,419 Cr | ₹1,591 Cr | ₹1,403 Cr | ₹942 Cr |
Cash Flow from Operating Activities | ₹1,813 Cr | ₹920 Cr | ₹1,137 Cr | ₹1,072 Cr | ₹600 Cr |
Cash Flow from Investing Activities | ₹-1,054 Cr | ₹-1,369 Cr | ₹-1,222 Cr | ₹-439 Cr | ₹-444 Cr |
Cash Flow from Financing Activities | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr | ₹-527 Cr | ₹-175 Cr |
Net Cash Inflow / Outflow | ₹19 Cr | ₹155 Cr | ₹-93 Cr | ₹106 Cr | ₹-19 Cr |
Opening Cash & Cash Equivalents | ₹283 Cr | ₹127 Cr | ₹220 Cr | ₹116 Cr | ₹136 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹2.32 Cr | ₹0.48 Cr | ₹0.38 Cr | ₹3.60 Cr | ₹-0.02 Cr |
Closing Cash & Cash Equivalent | ₹305 Cr | ₹283 Cr | ₹127 Cr | ₹226 Cr | ₹116 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹84,588.7 Cr | -6.1% | -11.9% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,290.0 Cr | -0.9% | 0.9% | 62.6% | Stock Analytics | |
CIPLA | ₹113,357.0 Cr | 3.5% | 4.2% | 51.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹111,134.0 Cr | 12.2% | 18% | 103.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,235.0 Cr | 0.8% | 5.6% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,001.5 Cr | -1% | -2.4% | 28.4% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -6.1% |
-11.9% |
54.1% |
SENSEX | 1.7% |
1.5% |
18.7% |
You may also like the below Video Courses